UI Heart and Vascular Center offers first non-surgical treatment for tricuspid valve regurgitation in Iowa
University of Iowa Hospitals & Clinics is the first and only hospital in Iowa to offer a transcatheter repair option for patients with tricuspid valve regurgitation. This condition causes blood to leak backwards into the upper right chamber of the heart. Patients with tricuspid valve regurgitation are usually sick with multiple conditions and don’t have many treatment options.
This new treatment option is as part of a national clinical trial. The trial allows the University of Iowa, the only participating institution in the state, to offer a less-invasive procedure than open-heart surgery.
The new treatment option brings together the leaflets of the heart valve to stop blood from leaking. UI Health Care experts have extensive training in repairing other heart valves using a similar technique for high-risk cases. We have comprehensive teams composed of interventional cardiologists, cardiac surgeons, and imaging cardiologists who review every case to provide the best treatment option tailored for the individual patient.
Patients with this condition can ask their provider for a referral to the Structural Heart Disease Program to be evaluated for this trial.
UI Heart and Vascular Center is the only comprehensive heart center in Iowa offering treatment options for the most complex heart conditions, and clinical trials are bringing new treatment options to all Iowans.
